Report : North America Hypodermic Needles Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Safety Needles, and Non-safety Needles), Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End-Users (Diagnostic Centers, Hospitals and Clinics, and Home Health Care), and Usage (Disposable, and Reusable)
Safety Needles Segment has the Largest Share of Type in the North America Hypodermic Needles Market during 2021–2028
According to our latest study on “North America Hypodermic Needles Market Forecast to 2028 – COVID-19 Impact and Analysis – by Type, Application, End User, and Usage,” the market is projected to reach US$ 2,427.9 million by 2028 from US$ 1,513.40 million in 2021; it is expected to grow at a CAGR of 7.0% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of chronic diseases, and surge in demand for vaccines. However, availability of alternatives is hampering the growth of the market to a certain extent.
The COVID-19 pandemic has resulted in many hospital admissions. These hospital admissions are followed by various tests using blood samples and various medications, which is expected to further fuel the market growth. Also, the rise in COVID-19 vaccinations has been observed, which will lead to increased demand for syringes and needles. The vaccine campaign has placed the spotlight on syringes and needles. Companies in the hypodermic needles are capitalizing on business opportunities with unprecedented demand for single-use needles. The COVID-19 pandemic has necessitated rapid vaccine development for the control of the disease. Most vaccinations, including those currently approved for COVID-19, are administered intramuscularly and subcutaneously using hypodermic needles. Manufacturers in the hypodermic needles market are maintaining robust supply chains to meet requirements for vaccine campaigns and ongoing COVID-19 cases of patients in hospitals.
Based on type, the North America hypodermic needles market is bifurcated into safety needles and non-safety needles. In 2021, the safety needles segment is estimated to account for the largest market share of the type segment in the North America hypodermic needles market. The growth of these segments is attributed to increasing prevalence of chronic disease, increasing needle stick injuries, and increasing regulation to reduce disease transmission through syringes.
EXELINT International, Co., Terumo Corporation, BD, B. Braun Melsungen AG, Catalent Inc., Cardinal Health Inc., Vita Needle Company, Connecticut Hypodermics Inc., Vygon, Barber of Sheffield, RETRACTABLE TECHNOLOGIES, INC., and AIR-TITE PRODUCTS CO., INC. are among the leading companies in the North America hypodermic needles market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for hypodermic needles market is segmented into type, application, end user, and usage. Based on type, the North America hypodermic needles market is segmented into safety needles, and non-safety needles. Based on application, the hypodermic needles market is segmented into drug delivery, vaccination, and blood specimen collection. Based on end user, the hypodermic needles market is segmented into diagnostic centers, hospitals and clinics, and home health care. Based on usage, the hypodermic needles market is segmented into disposable, and reusable. Geographically, the hypodermic needles market is segmented into North America (US, Canada, Mexico).
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com